Hos patienter, der tidligere havde fået kemoterapi, var den gennemsnitlige overlevelsestid for patienter, der fik Alimta, 8, 3 måneder, sammenlignet med 7, 9 måneder for dem, der fik docetaxel.
In patients who had received chemotherapy in the past, the average survival time was 8.3 months with Alimta, compared with 7.9 months with docetaxel.